Study Designs Available for Pharmacoepidemiology Studies

Pharmacoepidemiology, Fourth Edition

Volumn , Issue , 2007, Pages 17-28

  Strom, Brian L ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Case studies and case series; Causal nature of association criteria; Clinical, regulatory, commercial, and legal decisions; Dose response and duration response relationship; Epidemiologic study designs; Observational study designs or nonexperimental study designs; Pharmacoepidemiology and clinical pharmacology; Secular trend analyses and cohort and case control studies; Specific study designs in epidemiologic studies

Indexed keywords

EID: 84889377091     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470059876.ch2     Document Type: Chapter

References (49)

1. Lilienfeld DE, Stolley P. Foundations of Epidemiology, 3rd edn. New York: Oxford University Press, 1994.
2. MacMahon B, Pugh TF. Epidemiology: Principles and Methods. Boston, MA: Little, Brown, 1970.
3. Friedman G. Primer of Epidemiology, 3rd edn. New York: McGraw Hill, 1994.
4. Mausner JS, Kramer S. Epidemiology: An Introductory Text, 2nd edn. Philadelphia, PA: Saunders, 1985.
5. Ahlbom A, Norell S. Introduction to Modern Epidemiology, 2nd edn. Chestnut Hill, MA: Epidemiology Resources, 1990.
6. Sackett DL, Haynes RB, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine, 2nd edn. Boston, MA: Little, Brown, 1991.
7. Schuman SH. Practice-Based Epidemiology. New York: Gordon and Breach, 1986.
8. Rothman KJ, Greenland S. Modern Epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven, 1998.
9. Weiss N. Clinical Epidemiology: The Study of the Outcome of Illness, 2nd edn. New York: Oxford University Press, 1996.
10. Kelsey JL, Thompson WD, Evans AS. Methods in Observational Epidemiology, New York: Oxford University Press, 1986.
11. Hennekens CH, Buring JE. Epidemiology in Medicine, Boston, MA: Little, Brown, 1987.
12. Fletcher RH, Fletcher SW, Wagner EH. Clinical Epidemiology: The Essentials, 3rd edn. Baltimore, MD: Williams and Wilkins, 1996.
13. Hulley SB, Cummings SR. Designing Clinical Research: An Epidemiologic Approach, Baltimore, MD: Williams and Wilkins, 1988.
14. Gordis L. Epidemiology, 2nd edn. Philadelphia, PA: Saunders, 2000.
15. Rothman KJ. Epidemiology: An Introduction, New York: Oxford University Press, 2002.
16. Nieto FJ, Szklo M. Epidemiology: Beyond the Basics, Frederick, MD: Aspen, 1999.
17. Jekel JF, Elmore JG, Katz DL. Epidemiology, Biostatistics, and Preventive Medicine, Philadelphia, PA: Saunders, 1996.
18. Aschengrau A, Seage GR. Essentials of Epidemiology in Public Health, Sudbury, MA: Jones and Bartlett, 2003.
19. Friis RH, Sellers TA. Epidemiology for Public Health Practice, 2nd edn. Frederick, MD: Aspen, 1999.
20. Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB. Designing Clinical Research: An Epidemiologic Approach, 2nd edn. Baltimore, MD: Williams and Wilkins, 2001.
21. Greenberg RS, Daniels SR, Flanders WD, Eley JW, Boring JR. Medical Epidemiology, 3rd edn. New York: McGraw-Hill, 2001.
22. Wassertheil-Smoller S. Biostatistics and Epidemiology: A Primer for Health Professionals, New York: Springer-Verlag, 2003.
23. Katz DL. Clinical Epidemiology and Evidence-Based Medicine: Fundamental Principles of Clinical Reasoning and Research, Thousand Oaks, CA: Sage, 2001.
24. Sackett DL. Bias in analytic research. J Chronic Dis 1979; 32: 51-63.
25. Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 1986; 123: 670-6.
26. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295-300.
27. US Public Health Service. Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington DC: Government Printing Office, 1964; p. 20.
28. Experimental Carcinogenesis with Tobacco Smoke. In: US Public Health Service: The Health Consequences of Smoking- Cancer. A Report of the Surgeon General. Washington, DC: Government Printing Office, 1982; p. 181.
29. Biomedical evidence for determining causality. In: US Public Health Service: The Health Consequences of Smoking- Cancer. A Report of the Surgeon General. Washington, DC: Government Printing Office, 1982; p. 13.
30. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971; 284: 878-81.
31. Joint Commission on Prescription Drug Use. Final Report. Washington, DC, 1980.
32. Humphries TJ, Myerson RM, Gifford LM, Aeugle ME, Josie ME, Wood SL, et al. A unique postmarket outpatient surveillance program of cimetidine: report on phase II and final summary. Am J Gastroenterol 1984; 79: 593-6.
33. Markush RE, Seigel DG. Oral contraceptives and mortality trends from thromboembolism in the United States. Am J Public Health 1969; 59: 418-34.
34. National Center for Health Statistics. Health: United States 1982. Hyattsville, MD: Department of Health and Human Services, 1982.
35. US Public Health Service. Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington, DC: Government Printing Office, 1964; p. A1.
36. Strom BL, Stolley PD. Vascular and cardiac risks of steroidal contraception. In: Sciarra JW ed., Gynecology and Obstetrics, vol. 6. Hagerstown, MD: Harper and Row, 1989, pp. 1-17.
37. Bell RL, Smith EO. Clinical trials in post-marketing surveillance of drugs. Control Clin Trials 1982; 3: 61-8.
38. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523-34.
39. Herrington DM, Howard TD. From presumed benefit to potential harm-hormone therapy and heart disease. N Engl J Med 2003; 349: 519-21.
40. John B. Hormone-replacement therapy and cardiovascular diseases. N Engl J Med 2003; 349: 521-2.
41. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
42. Col NF, Pauker SG. The discrepancy between observational studies and randomized trials of menopausal hormone therapy: did expectations shape experience? Ann Intern Med 2003; 139: 923-9.
43. Grimes DA, Lobo RA. Perspectives on the Women's Health Initiative trial of hormone replacement therapy. Obstet Gynecol 2002; 100: 1344-53.
44. Whittemore AS, McGuire V. Observational studies and randomized trials of hormone replacement therapy: what can we learn from them? Epidemiology 2003; 14: 8-9.
45. Royal College of General Practitioners. Oral Contraceptives and Health. London: Pitman, 1974; ch.7.
46. Vessey MP, Doll R, Peto R, Johnson B, Wiggins P. A long-term follow-up study of women using different methods of contraception-an interim report. J Biosoc Sci 1976; 8: 373-427.
47. Mellin GW, Katzenstein M. The saga of thalidomide. N Engl J Med 1962; 267: 1238-44.
48. Taussig HB. A study of the German outbreak of phocomelia. JAMA 1962; 180: 1106-14.
49. Kajii T, Kida M, Takahashi K. The effect of thalidomide intake during 113 human pregnancies. Teratology 1973; 8: 163-6.